Yann-Alexandre Vano provides an overview of the biomarker-driven BIONIKK trial in metastatic renal cell carcinoma, and outlines the research needed to implement the findings clinically (4:02).
24-09-2020 | ESMO 2020 | Conference coverage | Video
24-09-2020 | ESMO 2020 | Conference coverage | Video
Yann-Alexandre Vano provides an overview of the biomarker-driven BIONIKK trial in metastatic renal cell carcinoma, and outlines the research needed to implement the findings clinically (4:02).